Jackson, Mississippi, United States The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Jackson.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Venture Incubator, LLC, startups are often financed by Groupon, BBVA Ventures, btov Partners. The meaningful sponsors for the fund in investment in the same round are Tally Capital, Novartis, Innovation Capital. In the next rounds fund is usually obtained by VI Partners AG, VINCI CAPITAL, Reference Capital SA.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Mobile Payments. Among the various public portfolio startups of the fund, we may underline SumUp, Kuros Biosciences, SMART VALOR The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 2 or 3 of the founder, the chance for it to get the investment is meager. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland.
The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2016. The important activity for fund was in 2006. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Venture Incubator, LLC works on 4 percentage points more the average amount of lead investments. The usual things for fund are deals in the range of 5 - 10 millions dollars.
Related Funds
| Fund Name | Location |
| Armory Square Ventures | New York, Syracuse, United States |
| Cantor Fitzgerald | New York, New York, United States |
| Cavallo Consulting | California, Corona, United States |
| Celanese | Irving, Texas, United States |
| Clal Insurance Enterprises Holdings | Israel, Kiryat Gat, South District |
| Convexa Capital Ventures | Norway, Oslo |
| EnBW | Baden-Wurttemberg, Germany, Karlsruhe |
| Halyard Capital | New York, New York, United States |
| Hull Street Capital | Bethesda, Maryland, United States |
| iBelay | - |
| Intel | California, Santa Clara, United States |
| Mitsui Comtek | California, Cupertino, United States |
| Mochishan Venture Capital | - |
| Mount Nathan Advisors | Central, Central Region, Singapore |
| O.R.Technologies | - |
| Pritzker Private Capital | Chicago, Illinois, United States |
| UNITED, Inc. | Japan, Kanagawa Prefecture, Kawasaki |
| White Road Investments | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Covalys Biosciences | 06 Mar 2006 | Bern, Switzerland | |||
Kuros Biosciences | $8M | 05 Nov 2002 | Zurich, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Covalys Biosciences | 06 Mar 2006 | Bern, Switzerland | |||
Kuros Biosciences | $8M | 05 Nov 2002 | Zurich, Switzerland |
